Abstract
We investigated whether differences in IL-6 and IL-1β expression could be detected in monoclonal plasma cells from patients with MGUS or MM. Expression of IL-6 and IL-1β in bone marrow cells was determined using cell sorting to enrich for plasma cells followed by reverse transcriptase/polymerase chain reaction (RT/PCR). Nineteen patients (six MGUS, two primary amyloid (AL), 11 MM) were studied. IL-6 mRNA expression was detectable in the sorted CD38+/CD45− plasma cell populations from 0/6 MGUS, 0/2 AL and 5/11 MM patients. All five MM patients with autocrine IL-6 expression demonstrated an elevated plasma cell labeling index. IL-1β mRNA was detectable in the sorted CD38+/CD45− plasma cell populations from 1/6 MGUS, 0/2 AL and 10/11 MM patients. In situ hybridization (ISH) confirmed that the IL-1β producing cells were plasma cells. In conclusion, autocrine production of IL-6 parallels a high labeling index and aberrant expression of IL-1β correlates with the diagnosis of MM. Follow-up of IL-1β-positive MGUS patients will determine whether aberrant expression of IL-1β will predict those MGUS patients that will eventually progress to MM.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Donovan, K., Lacy, M., Kline, M. et al. Contrast in cytokine expression between patients with monoclonal gammopathy of undetermined significance or multiple myeloma. Leukemia 12, 593–600 (1998). https://doi.org/10.1038/sj.leu.2400873
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.leu.2400873
Keywords
This article is cited by
-
Elevated pre-transplant C-reactive protein identifies a high-risk subgroup in multiple myeloma patients undergoing delayed autologous stem cell transplantation
Bone Marrow Transplantation (2018)
-
Interleukin-1 Blockade: An Update on Emerging Indications
BioDrugs (2017)
-
IL-1β expression in IgM monoclonal gammopathy and its relationship to multiple myeloma
Leukemia (2002)
-
Biological features of the clone involved in primary amyloidosis (AL)
Leukemia (2001)